Lonza: Pierre-Alain Ruffieux, CEO
Lonza has elected Pierre-Alain Ruffieux CEO, effective November 1. Ruffieux currently serves as head of global pharma technical operations firm, where he leads a 12,000-person team in various aspects of commercial pharmaceutical manufacturing, supply chain operations, technical issues, quality assurance and regulatory matters.
Ruffieux’s 20-plus years of biopharmaceutical industry experience includes roles of increasing seniority at Novartis. “I am delighted to have been appointed as CEO of Lonza. Having been a customer over many years, I greatly admire Lonza’s technology and people,” Ruffieux said.
“I look forward to building on its many successes in the years to come,” he added.